Top 20 Key Players companies in Hemorrhagic Fevers by Highest Patent Value in the world in 2022 – Discovery

Free Trial

The Hemorrhagic Fevers top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Hemorrhagic Fevers Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Viral hemorrhagic fevers (VHFs) are a group of illnesses caused by four families of viruses. These include the Ebola and Marburg, Lassa fever, and yellow fever viruses. VHFs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. Some VHFs cause mild disease, but some, like Ebola or Marburg, cause severe disease and death.

VHFs are found around the world. Specific diseases are usually limited to areas where the animals that carry them live. For example, Lassa fever is limited to rural areas of West Africa where rats and mice carry the virus.

The risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. Because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism.

Centers for Disease Control and Prevention

1	Seek Ltd. (UK)	United Kingdom	Over-the-counter	Avg patent value: 3.32 M
2	Ningbo Health Gene Technologies Co. Ltd.	Zhejiang Sheng, China	Clinical research,Molecular diagnostics,Nucleic Acid Testing	Avg patent value: 160,000
3	ImmuneMed, Inc.	Kangwŏn-do, South Korea	Scrub typhus,Leptospira,Murine typhus, ...[+2]	Avg patent value: 153,000
4	Weifang Kanghua Biotechnology Co. Ltd.	China		Avg patent value: 140,000
5	Ibis Biosciences LLC	California, United States	Assay,Mitochondrial DNA,Biological organism, ...[+2]	Avg patent value: 99,000
6	STARTUP Navigen, Inc.	Utah, United States	Drug discovery,Medicine,Health care, ...[+2]	Avg patent value: 70,000
7	Firebrick Pharma Ltd.	Victoria, Australia	Herb,Botanical drug	Avg patent value: 67,000
8	Dong-E-E-Jiao Co., Ltd.	Shandong Sheng, China	Herb,Medicine,Herb medicine, ...[+1]	Avg patent value: 43,000
9	The Broad Institute, Inc.	Massachusetts, United States	Clinical trial,Biology,Genomics, ...[+2]	Avg patent value: 17,000
10	STARTUP Tremeau Pharmaceuticals, Inc.	Massachusetts, United States	Cyclooxygenase,Medicine,Clinical trial, ...[+2]	Avg patent value: 16,000
11	Royal (Wuxi) Bio-Pharmaceutical Co., Ltd.	Jiangsu Sheng, China	Medicine,Diagnostic Reagent,Biological product	Avg patent value: 3,500
12	Canon, Inc.	Tokyo, Japan	Computer hardware,Software,Computer vision, ...[+2]	Avg patent value: 0
13	Eli Lilly & Co.	Indiana, United States	Medicine,Health care,Humalog Mix, ...[+2]	Avg patent value: 0
14	CJ CheilJedang Corp.	South Korea	Sugar,Food processing,Food industry, ...[+2]	Avg patent value: 0
15	CJ Corp.	South Korea	Biotechnology,Pharmaceutics,Shopping mall, ...[+2]	Avg patent value: 0
16	Ionis Pharmaceuticals, Inc.	California, United States	Drug,Health care,Drug discovery, ...[+2]	Avg patent value: 0
17	Green Cross Holdings Corp.	South Korea	Clinical trial,Pharmacy,Medicine, ...[+2]	Avg patent value: 0
18	Boryung Corp.	South Korea	Medicine,Health care,Amino acid, ...[+2]	Avg patent value: 0
19	ORIENTBIO, Inc.	Gyeonggi-do, South Korea	Biological materials,Contract research organization,Biotechnology	Avg patent value: 0
20	Arbutus Biopharma Corp.	British Columbia, Canada	Medicine,Health care,Drug, ...[+2]	Avg patent value: 0